Concepedia

Author

J. Carpenter

University of Alabama at Birmingham

Also Known As

H L Laws, J Carpenter, J T Carpenter, J. Carpenter, J. T. Carpenter, J.T. Carpenter, JT Carpenter

35

Publications

930

Citations

9

H-Index

23

Concepts

All Affiliations

University of Alabama at BirminghamUniversity of Virginia
JC

About

J. Carpenter is an author at University of Alabama at Birmingham specializing in oncology, medicine, and breast cancer.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

778

2

Health Sciences

2

2

135

3

Biochemistry

1

1

37

4

Cell Biology

1

1

37

5

Gastroenterology

1

1

27

J. Carpenter

×

9

Publications

880

Citations

9

H-Index

YearCitations

Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women

I. Craig Henderson, H.T. Mouridsen, O Abe,

1988

628

Randomized 3-arm, phase 2 study of temsirolimus (CCI-779) in combination with letrozole in postmenopausal women with locally advanced or metastatic breast cancer

J. Carpenter, H. Roché, Mario Campone,

Journal of Clinical Oncology

2005

98

Megestrol acetate v tamoxifen in advanced breast cancer: correlation of hormone receptors and response.

David S. Ettinger, Joseph C. Allegra, Joseph R. Bertino,

PubMed

1986

39

Human Erythrocyte Catalase: Demonstration of Heterogeneity and Relationship to Erythrocyte Ageing <i>in vivo</i>

O. A. Thorup Junr, J. Carpenter, Paul Howard

British Journal of Haematology

1964

37

Phase II evaluation of bolus gallium nitrate in lymphoproliferative disorders: a Southeastern Cancer Study Group trial.

Jacqui Keller, A Bartolucci, J. Carpenter,

PubMed

1986

27

Use of megestrol acetate in advanced breast cancer on a single-daily-dose schedule.

J. Carpenter, LL Peterson

PubMed

1985

15

Abstract PD1-6: A randomized phase II neoadjuvant study of cisplatin, paclitaxel with or without everolimus (an mTOR inhibitor) in patients with stage II/III triple-negative breast cancer (TNBC)

IA Mayer, Bojana Jovanović, V Abramson,

Cancer Research

2013

14

Ineffectiveness of levamisole in prolonging remission or survival of women treated with cyclophosphamide, doxorubicin, and 5-fluorouracil for good-risk metastatic breast carcinoma: a Southeastern Cancer Study Group Trial.

J. Carpenter, Smalley Rv, M Raney,

PubMed

1986

11

Phase II evaluation of fludarabine in patients with metastatic breast cancer: a Southeastern Cancer Study Group trial.

J. Carpenter, C. L. Vogel, G Wang,

PubMed

1986

11

Page 1